This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

AVAC Applauds New WHO ARV Guidelines As Critical Step; Must Be Paired With Equally Bold HIV Prevention To End AIDS

NEW YORK, June 30, 2013 /PRNewswire-USNewswire/ -- New World Health Organization (WHO) guidelines that will greatly expand the number of people eligible for antiretroviral (ARV) treatment around the world are critical and must be implemented with comprehensive programs to curb new HIV infections in order to stay on the road to ending AIDS, AVAC said today.

"These guidelines are a landmark in the fight against AIDS," said Mitchell Warren, AVAC executive director. "But guidelines alone don't save lives – money, pills and smart programs save lives. Investment and effective implementation will be critical."

"Expanding HIV treatment is a global imperative, but it can't be done in isolation," Warren added. "To reach the tipping point against AIDS, we need to dramatically slow new HIV infections. The prevention benefits of treatment will get us part of the way there, but not all the way. We have to scale up every prevention option we have, including male circumcision, PrEP, male and female condoms and clean injecting equipment, while pressing ahead in the development of microbicides, vaccines and other new prevention strategies."

"Different people need different options.  While these guidelines are based on a broad range of evidence, earlier HIV treatment may not be right for everyone.  Individuals must make their own choices about when they are ready to start HIV therapy," Warren said.

AVAC, together with amfAR, has called on policymakers, funders, governments and civil society to achieve a "tipping point" in the global AIDS epidemic, at which the rate of treatment initiation (expansion of people gaining access to treatment) exceeds the number of people becoming newly infected. This goal and other long-term shifts in rates of new HIV infections and deaths are only possible with a surge of investment and implementation in the short-term. AVAC urges immediate action on this critical issue. With aggressive investment, a tipping point could be reached in a number of countries in the next three years. For more, visit www.endingaids.org.

SOURCE AVAC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,387.21 -291.49 -1.65%
S&P 500 2,029.55 -27.54 -1.34%
NASDAQ 4,681.4970 -90.2660 -1.89%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs